Abstract:Tumor-associated macrophages (TAMs) are major innate immune cells that constitute up to 50% of the cell mass of human tumors. TAMs are highly heterogeneous cells that originate from resident tissue-specific macrophages and from newly recruited monocytes. TAMs' variability strongly depends on cancer type, stage, and intratumor heterogeneity. Majority of TAMs are programmed by tumor microenvironment to support primary tumor growth and metastatic spread. However, TAMs can also restrict tumor growth and metastasis. In this review, we summarized the knowledge about the role of TAMs in tumor growth, metastasis and in the response to cancer therapy in patients with five aggressive types of cancer: breast, colorectal, lung, ovarian, and prostate cancers that are frequently metastasize into distant organs resulting in high mortality of the patients. Two major TAM parameters are applied for the evaluation of TAM correlation with the cancer progression: total amount of TAMs and specific phenotype of TAMs identified by functional biomarkers. We summarized the data generated in the wide range of international patient cohorts on the correlation of TAMs with clinical and pathological parameters of tumor progression including lymphatic and hematogenous metastasis, recurrence, survival, therapy efficiency. We described currently available biomarkers for TAMs that can be measured in patients' samples (tumor tissue and blood). CD68 is the major biomarker for the quantification of total TAM amounts, while transmembrane receptors (stabilin-1, CD163, CD206, CD204, MARCO) and secreted chitinase-like proteins (YKL-39, YKL-40) are used as biomarkers for the functional TAM polarization. We also considered that specific role of TAMs in tumor progression can depend on the localization in the intratumoral compartments. We have made the conclusion for the role of TAMs in primary tumor growth, metastasis, and therapy sensitivity for breast, colorectal, lung, ovarian, and prostate cancers. In contrast to other cancer types, majority of clinical studies indicate that TAMs in colorectal cancer have protective role for the patient and interfere with primary tumor growth and metastasis. The accumulated data are essential for using TAMs as biomarkers and therapeutic targets to develop cancer-specific immunotherapy and to design efficient combinations of traditional therapy and new immunomodulatory approaches.

The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration

Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer

The clinicopathological impact of tumor-associated macrophages in patients with cutaneous malignant melanoma

Prognostic Value Of Tumor-Associated Macrophages In Clear Cell Renal Cell Carcinoma: A Systematic Review And Meta-Analysis

Prognostic Significance Of Tumor-Associated Macrophages In Breast Cancer: A Meta-Analysis Of The Literature

Phenotyping of tumor-associated macrophages in colorectal cancer: Impact on single cell invasion (tumor budding) and clinicopathological outcome

Tumor-associated Macrophages As Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer.

Tumor-Associated Macrophages As Predictive Biomarkers For Postoperative Adjuvant Chemotherapy In Patients With Stage Ii Colon Cancer.

Tumor-Associated Macrophages in Tumor Immunity (vol <i>11</i>, <i>583084</i>, <i>2020</i>)

Prognostic impact of tumor-associated macrophage infiltration in esophageal cancer: a meta-analysis

Prognostic Value of Diametrically Polarized Tumor-Associated Macrophages in Renal Cell Carcinoma

Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers

Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry

Tumor-associated macrophages remodeling EMT and predicting survival in colorectal carcinoma.

Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis

Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis.

CD 68-positive tumor-associated macrophages predicts the survival of patients with stage I colorectal cancer

Tumor-associated macrophages: Potential therapeutic targets and diagnostic markers in cancer

CXCR6+ tumor-associated macrophages identify immunoevasive colon cancer patients with poor prognosis but favorable response to adjuvant chemotherapy

Functional and Therapeutic Significance of Tumor-Associated Macrophages in Colorectal Cancer